NL-OMON22991已完成不适用
Pneumonia treated with RIfampicin aTtenuates INflammation.
Prof. dr. J.T. van DisselLUMC0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patient aged 18 years or above;
- •2. Hospitalization for community acquired pneumonia with CURB65 score ≥ 2.
排除标准
- •1. Known allergy to rifampicin or other rifamycins;
- •2. Haemolytic anaemia or thrombopenia as side effect of rifampicin in medical history;
研究者
相似试验
已完成
4 期
Pneumonia treated with rifampicine attenuates inflammatio1000401810024970respiratory tract infectionpneumoniaNL-OMON39089eids Universitair Medisch Centrum40
进行中（未招募）
不适用
rifampicine bij longontsteking vermindert de ontstekingsreactieEUCTR2012-003067-22-NLMC
已完成
不适用
A clinical trial to study the effect of Rifampicin in children with bacterial meningitisCTRI/2015/06/005951PGIMER40
已完成
4 期
Investigation of Rifampin to Reduce Pedal Amputations for Osteomyelitis in DiabeticsAmputationDiabetesOsteomyelitisNCT03012529VA Office of Research and Development843
进行中（未招募）
1 期
CLINICAL TRIAL TO EVALUATE THE EFFICIENCY OF PYRPHENIDONE FOR THE REDUCTION OF PULMONARY INFLAMMATION IN PATIENTS WITH SILICOSIS AND PROGRESSIVE MASSIVE FIBROSIS.progressive massive fibrosisMedDRA version: 20.0Level: PTClassification code 10040678Term: SilicosisSystem Organ Class: 10022117 - Injury, poisoning and procedural complicationsMedDRA version: 21.1Level: PTClassification code 10036805Term: Progressive massive fibrosisSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2021-002701-94-ESFundación para la Gestión de la Investigación Biomédica de Cádiz18